Avricore Health (AVCRF) Payables (2009 - 2026)

Avricore Health (AVCRF) has reported Payables for 18 consecutive years, with $283782.1 the latest figure, recorded in Q1 2026.

• In Q1 2026, Payables rose 117.69% year-over-year to $283782.1; the TTM figure through Mar 2026 stood at $283782.1 (up 117.69% YoY), while the FY2025 annual figure was $124221.3, down 48.59% from the prior year.
• Payables improved to $283782.1 in Q1 2026 per AVCRF's latest filing, from $124458.2 in the prior quarter.
• Across five years, Payables topped out at $452405.3 in Q3 2023 and bottomed at $20904.5 in Q1 2022.
• Historically, Payables has averaged $219078.1 across 5 years, with a median of $236815.1 in 2024.
• Annual changes were most pronounced in 2023 — Payables surged 1203.87% — and 2025, when it tumbled 93.38%.
• Avricore Health's Payables stood at $192642.7 in 2022, then jumped by 63.45% to $314878.5 in 2023, then slipped by 24.79% to $236815.1 in 2024, then tumbled by 47.44% to $124458.2 in 2025, then jumped by 128.01% to $283782.1 in 2026.
• Business Quant data shows AVCRF's Payables at $283782.1 in Q1 2026, $124458.2 in Q4 2025, and $26075.3 in Q3 2025.